VeriMomHamilelikte gemfibrozil kullanmaktan kaçınmalı mıyım? | VeriMom
Animal reproductive and developmental toxicity (rats/rabbits) reported (dose-related decreases in conception, increased stillbirths, fetal skeletal variations and rare anophthalmia); regulatory/product literature flags suspected reproductive toxicity (H361) though no clear harmonised CLP entry was found. Mechanism is not well‑characterized for reproductive effects; likely related to pharmacologic/lipid‑metabolism effects seen with systemic exposure. Topical cosmetic exposure would give low but measurable systemic absorption in typical circumstances, so exposure is not negligible for pregnancy concerns. Sources: Drugs.com summary (drug pregnancy warnings), product monograph and animal study summaries, SDS/classification listings.
ECHA regulatory hazard statements
- •H360D
- •H361
What to use instead
Pregnancy-safe ingredients that serve a similar function:
FAQ
- gemfibrozil hamilelikte güvenli mi?
- Animal reproductive and developmental toxicity (rats/rabbits) reported (dose-related decreases in conception, increased stillbirths, fetal skeletal variations and rare anophthalmia); regulatory/product literature flags suspected reproductive toxicity (H361) though no clear harmonised CLP entry was found. Mechanism is not well‑characterized for reproductive effects; likely related to pharmacologic/lipid‑metabolism effects seen with systemic exposure. Topical cosmetic exposure would give low but measurable systemic absorption in typical circumstances, so exposure is not negligible for pregnancy concerns. Sources: Drugs.com summary (drug pregnancy warnings), product monograph and animal study summaries, SDS/classification listings.
- gemfibrozil emzirirken güvenli mi?
- Authoritative lactation sources (LactMed / drug monographs) advise avoidance during breastfeeding because of concern for disruption of infant lipid metabolism and because gemfibrozil is systemically absorbed and may transfer to milk. Reproductive/developmental animal data support suspected hazard. Topical cosmetic use would generally give low exposure, but milk transfer risk under systemic use is established. Sources: LactMed, product monograph, Drugs.com.
- gemfibrozil bebek cildi için güvenli mi?
- Because animal developmental toxicity has been observed, hazard for infants is flagged as suspected (H361 in several supplier/SDS listings and regulatory summaries). For infant skin (0–3 yr) exposure, immature skin increases absorption; therefore exposure score is increased by +1 relative to adult topical exposure. There are no infant‑specific dermal studies for gemfibrozil in cosmetics, and no SCCS/CIR cosmetic safety opinion was located; concern is driven by systemic reproductive/developmental toxicity observed in animal studies and regulatory/product literature. Sources: SDSs and product monograph reporting reproductive effects, LactMed, animal study summaries.
- VeriMom gemfibrozil nasıl puanlıyor?
- VeriMom gemfibrozil'yi EU CosIng, ECHA sınıflandırmaları ve PubMed çalışmalarına göre 27/100 (yüksek risk) olarak puanlar.
- Hamilelikte gemfibrozil yerine neler kullanılabilir?
- Benzer işlevli ve bilinen riski olmayan alternatifleri içeren listemize bakın.
Her etiketi 2 saniyede kontrol et
VeriMom'u ücretsiz indirin — herhangi bir ürünü tarayın ve hamilelik güvenlik puanını anında görün.
Tıbbi Sorumluluk Reddi
Bu bilgiler yalnızca eğitim amaçlıdır ve tıbbi tavsiye niteliği taşımaz. Güvenlik puanları kamuya açık verilere dayanmaktadır ve tüm riskleri yansıtmayabilir. Hamilelik veya emzirme döneminde herhangi bir ürünü kullanmadan önce her zaman sağlık uzmanınıza danışın.